Moderna announces $4.9bn in profits, raises 2022 forecast
U.S. Biotech Company Moderna has continues to reap the rewards of its COVID-19 vaccine. In the final quarter of 2021, the company had achieved net profits of $4.9 billion, it announced on Thursday. In the last fiscal year, Moderna made a surplus of $12.2 billion, although the high research and development costs of the previous […]
